DSN, Canadian Pharmacists Association hold groundbreaking event in TorontoThe event explored ways the two countries can learn from each other. Fresenius inks licensing agreement to commercialize proposed Aflibercept biosimilarAflibercept is used to treat a range of ophthalmic disorders, including wet age-related macular degeneration. Lupin receives nod for generic Adderall XR, launches generic Bumex Generic Adderall XR capsules are indicated for the treatment of ADHD in adults and pediatric patients 6 years and older. Teva, mAbxience expand partnership for additional oncology biosimilar candidate The licensing agreement includes exclusive rights for multiple markets, including Europe and the United States. Amicus Therapeutics settles Galafold patent litigation with Teva Amicus has granted Teva a license to market generic Galafold beginning in January 2037. Viatris inks deal with Lexicon for sotagliflozin outside of U.S., Europe Sotagliflozin is used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults. XiFin earns 2024 HITRUST R2 certification for 2nd 2-year term The certification verifies that XiFin RPM meets requirements for safeguarding sensitive data. Former FDA commissioner Janet Woodcock to headline AAM’s GRx+Biosims conference The conference takes place in Rockland, Md., Oct. 21-23. NCPA pushes CMS for regulations outlining PBM contracting guardrails NCPA is urging CMS to eliminate abuses by plans and PBMs in Part D and ensure patient access to accurate information. Expanding pharmacy care Several factors may be at play in creating pharmacy deserts. 1 2 3 4 5 Next Last
